{"id":104239,"date":"2023-06-19T13:25:00","date_gmt":"2023-06-19T07:55:00","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=104239"},"modified":"2023-06-19T13:25:24","modified_gmt":"2023-06-19T07:55:24","slug":"pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/","title":{"rendered":"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2624694050\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday&#8217;s first half session.&nbsp;The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China&#8217;s National Medical Products Administration (NMPA).<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1980709081\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>According to the exchange filing, the Company obtained approval from China&#8217;s National Medical Products Administration (NMPA to promote Prilocaine (API), an anaesthetic medication, in China. At 12:15 hrs, the stock was trading at&nbsp; Rs 240.50 on the NSE, up 3.78 percent from its previous close.<\/p><p>In the last three months, the stock grew from Rs 203.50 to current levels by 17.57 percent and climbed by 22.41 percent from Rs 195.70 to current values.&nbsp;<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GUFICBIO\/standalone?standalone=true\" target=\"_blank\" rel=\"noreferrer noopener\">Gufic Bioscience<\/a><\/strong> is engaged in the Research and Development, manufacturing, marketing, and distribution of pharmaceutical products and it is one of the largest manufacturers of Lyophilized injections in India. The company caters to the domestic and international markets.<\/p><div class=\"trade-content_5\" id=\"trade-728041573\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company&#8217;s financial reports show that net profit significantly decreased by 10% in Q4FY23 from Q4FY22 to Rs 18 crore. Additionally, operational income rose from Rs 162 crore in the same time last year to Rs 173 crore, a 7 percent gain.&nbsp;<\/p><p>On a year-to-year basis, the revenue fell by 11 percent, from Rs 779 crores in FY 21\u201322 to Rs 690 crores in FY 22\u201323. During the same time frame, the Net Profit decreased by 17 percent, falling from Rs 95 crores to Rs 79 crores.&nbsp;<\/p><p>The profitability ratios for FY23 were 22.91 percent ROE and 20.06 percent ROCE. The operating margin increased to 16.64 percent, while the net profit margin was at 11.54 percent.<\/p><p>As per the shareholding pattern, promoters of the company hold a 75 percent stake and retail investors hold a 23.12 percent stake in the company for FY 22-23.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Omkar C<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-611694246\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday&#8217;s first half session.&nbsp;The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China&#8217;s National Medical Products Administration (NMPA). According to the exchange [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":69898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[995,6616,3047,5890,3046,6617,2035,7780,7781,7782],"class_list":["post-104239","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-best-stocks-to-buy-in-pharma-sector","tag-pharma-stock","tag-pharma-stocks","tag-pharma-stocks-latest-news","tag-pharma-stocks-to-buy","tag-pharma-stocks-to-buy-now","tag-pharmaceutical-company","tag-small-cap-pharma-stock","tag-small-cap-pharma-stock-to-buy","tag-small-cap-pharma-stock-to-buy-now"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday&#039;s first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China&#039;s National Medical Products Administration (NMPA).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug\" \/>\n<meta property=\"og:description\" content=\"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday&#039;s first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China&#039;s National Medical Products Administration (NMPA).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-19T07:55:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-19T07:55:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/\",\"name\":\"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg\",\"datePublished\":\"2023-06-19T07:55:00+00:00\",\"dateModified\":\"2023-06-19T07:55:24+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday's first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China's National Medical Products Administration (NMPA).\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug - Trade Brains Features","description":"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday's first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China's National Medical Products Administration (NMPA).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug","og_description":"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday's first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China's National Medical Products Administration (NMPA).","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-06-19T07:55:00+00:00","article_modified_time":"2023-06-19T07:55:24+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/","name":"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg","datePublished":"2023-06-19T07:55:00+00:00","dateModified":"2023-06-19T07:55:24+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of Gufic BioSciences Ltd gained 5 percent, reaching a 52-week high of Rs 247 on Monday's first half session.\u00a0The company has a market capitalization of Rs 2,319 crores. Such a movement in the stock price was noticed after the company received approval from China's National Medical Products Administration (NMPA).","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/10\/Martkets-1214-Cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-5-after-the-company-received-approval-for-anaesthetic-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps up to 5% after the company received approval for Anaesthetic drug"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=104239"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104239\/revisions"}],"predecessor-version":[{"id":104242,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/104239\/revisions\/104242"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/69898"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=104239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=104239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=104239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}